-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$14.50148.29% Upside
Voyager Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Voyager Therapeutics, Inc.?
Voyager Therapeutics, Inc. has been rated by research analysts at Robert W. Baird, Wedbush, Wells Fargo, Truist Financial in the past 90 days.